In this editorial, which was published in the Palm Beach Post on April 22, 2019, Michelle Flowers writes about Florida’s history of black market cancer treatments and the danger importation poses to patients. Flowers is president of the Oncology Managers of Florida.
Read More
The proposed legislation, H.R. 6554, will require that anyone who owns, purchases or imports pill press must be registered them with the U.S. Attorney General.
Read MoreTallahassee, FL (April 18, 2019) – Today the Partnership for Safe Medicines released new ads to run in several parts of Florida that highlight the dangers of Florida attempting to import medicine from Canada. Five different commissioners of the US Food and Drug Administration, appointed by both Republicans and Democrats, have stated that such proposals are dangerous to patients, will expose them to counterfeits, and are unlikely to reduce the price of medicine.
Read More
In this editorial by Terry Wilcox published in Inside Sources on April 18, 2019, Terry Wilcox, executive director of a patient advocacy organization advices federal and state representatives that allowing drug importation is not the right policy solution for America’s high prescription drug prices…
Read More
In this editorial, which was published in Colorado Politics on April 17, 2019, Don Bell, a 30-year veteran of Canadian law enforcement and border protection, warns that Canadian drug importation will open the U.S. to counterfeit medicine and exacerbate drug shortages in Canada.
Read More
Counterfeit medicines kill up to 300,000 children each year In a shocking new report published in the American Journal of Tropical Medicine and Hygiene, researchers have documented the true toll of counterfeit medicines around the world due to medicine being subtherapeutic or outright ineffective. Subtherapeutic medicine allows patients to die without sufficient treatment, but…
Read More
The editorial board of the The Wall Street Journal published this editorial on April 15, 2019. In it, they write:
“The argument that drug importation threatens the integrity of the drug supply is often dismissed because pharmaceutical lobbyists make it. But keeping the drug supply free from contaminated or counterfeit products is not easy, and the World Health Organization has warned that 1 in 10 medical products in the developing world are phony. It isn’t clear who is liable if counterfeits are found in Florida, but you can bet it won’t be the politicians.”
Read More
April 12, 2019 (Tallahassee, FL) — Importation undermines our core efforts to keep our medicine supply safe. State and federal authorities regulate every entity in the U.S. supply chain from the point of manufacture until a medicine is dispensed, and that makes counterfeits in the legitimate supply chain rare. In 2013, Congress passed the Drug…
Read More
In March 2019, the U.S. Food and Drug Administration issued warning letters to a website and an online pharmacy network for selling misbranded mifepristone and misoprostol
Read More
In this editorial, which was published in The Gadsden Times on April 11, 2019, former FDA-OCI director George Karavetsos points out the real dangers of drug importation:
“Even today, Americans are being hurt and even dying because of counterfeit medications being imported into this country. Adding insult to injury, while some might point to Canada as being a safe source, counterfeit medications are transshipped through Canada from other countries in remote corners of the globe.”
Read More